+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Membrane type-matrix metalloproteinases and tumor progression

Membrane type-matrix metalloproteinases and tumor progression

Biochimie 87(3-4): 329-342

Matrix metalloproteinases (MMPs) are a family of zinc endopeptidases that process growth factors, growth factor binding proteins, cell surface proteins, degrade extracellular matrix (ECM) components and thereby play a central role in tissue remodeling and tumor progression. Membrane-type matrix metalloproteinases (MT-MMPs) are a recently discovered subgroup of intrinsic plasma membrane proteins. Their functions have been extended from pericellular proteolysis and control of cell migration to cell signaling, control of cell proliferation and regulation of multiple stages of tumor progression including growth and angiogenesis. This review sheds light on the new functions of MT-MMPs and their inhibitors in tumor development and angiogenesis, and presents recent investigations that document their influence on various cell functions.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 012297480

Download citation: RISBibTeXText

PMID: 15781320

DOI: 10.1016/j.biochi.2004.07.012

Related references

The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis. Turkish Journal of Gastroenterology 20(1): 41-47, 2009

Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. European Journal Of Biochemistry. 250(3): 751-757,., 1997

Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. European Journal of Biochemistry 250(3): 751-757, 1998

Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. Journal of Biochemistry 119(2): 209-215, 1996

Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases. Cancer Research 70(17): 6902-6912, 2010

Membrane type-1 matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 RNA levels mimic each other during Xenopus laevis metamorphosis. Plos One 2(10): E1000, 2007

Matrix metalloproteinases and tumor progression. Advances in Experimental Medicine and Biology 532: 91-107, 2003

Matrix metalloproteinases in tumor progression. Proceedings of the American Association for Cancer Research Annual Meeting 40: 769-770, March, 1999

Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. Journal of Cell Biology 149(6): 1309-1323, 2000

Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Reviews 14(4): 351-362, 1995

Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion and Metastasis 14(1-6): 234-245, 1994

Regulation of tumor progression of EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases. FASEB Journal 14(4): A540, March 15, 2000

Matrix metalloproteinases and their inhibitors in tumor progression. Annals of the New York Academy of Sciences 732: 222-232, 1994

Matrix-degrading metalloproteinases in tumor progression. Princess Takamatsu Symposia 24: 152-161, 1994

Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy. Small 10(3): 566-75, 417, 2014